CD8A and neoplasm: It is dually beneficial — it not only inhibits the numbers of immunosuppressive Tregs in the tumor, but also increases the numbers of intratumoral protective effector CD8+ T cells, presumably because they are not suppressed from proliferating in response to the tumor.